Medtronic ROE 2010-2025 | MDT
Current and historical return on equity (ROE) values for Medtronic (MDT) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Medtronic ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-01-31 | $4.26B | $49.62B | 8.65% |
| 2024-10-31 | $4.29B | $48.72B | 8.61% |
| 2024-07-31 | $3.93B | $48.16B | 7.77% |
| 2024-04-30 | $3.68B | $50.42B | 7.16% |
| 2024-01-31 | $4.20B | $52.00B | 8.13% |
| 2023-10-31 | $4.10B | $51.65B | 7.95% |
| 2023-07-31 | $3.62B | $51.37B | 7.01% |
| 2023-04-30 | $3.76B | $51.67B | 7.22% |
| 2023-01-31 | $4.06B | $51.62B | 7.77% |
| 2022-10-31 | $4.32B | $52.06B | 8.22% |
| 2022-07-31 | $5.21B | $52.84B | 9.89% |
| 2022-04-30 | $5.04B | $52.72B | 9.63% |
| 2022-01-31 | $4.91B | $52.71B | 9.44% |
| 2021-10-31 | $4.70B | $52.16B | 9.12% |
| 2021-07-31 | $3.88B | $51.66B | 7.59% |
| 2021-04-30 | $3.61B | $51.60B | 7.10% |
| 2021-01-31 | $2.89B | $50.93B | 5.71% |
| 2020-10-31 | $3.54B | $50.32B | 6.95% |
| 2020-07-31 | $4.41B | $50.44B | 8.65% |
| 2020-04-30 | $4.79B | $50.87B | 9.39% |
| 2020-01-31 | $5.32B | $51.95B | 10.45% |
| 2019-10-31 | $4.67B | $50.72B | 9.27% |
| 2019-07-31 | $4.42B | $50.50B | 8.82% |
| 2019-04-30 | $4.63B | $50.21B | 9.25% |
| 2019-01-31 | $4.92B | $49.94B | 9.80% |
| 2018-10-31 | $2.26B | $49.71B | 4.49% |
| 2018-07-31 | $3.16B | $50.33B | 6.23% |
| 2018-04-30 | $3.10B | $50.82B | 6.10% |
| 2018-01-31 | $2.81B | $50.34B | 5.53% |
| 2017-10-31 | $5.02B | $51.58B | 9.93% |
| 2017-07-31 | $4.12B | $50.79B | 8.19% |
| 2017-04-30 | $4.03B | $50.33B | 8.02% |
| 2017-01-31 | $3.97B | $49.49B | 7.83% |
| 2016-10-31 | $4.24B | $50.29B | 8.32% |
| 2016-07-31 | $3.65B | $50.89B | 7.08% |
| 2016-04-30 | $3.54B | $52.06B | 6.81% |
| 2016-01-31 | $2.43B | $50.82B | 4.66% |
| 2015-10-31 | $2.32B | $52.27B | 5.19% |
| 2015-07-31 | $2.62B | $52.81B | 7.21% |
| 2015-04-30 | $2.68B | $53.23B | 9.55% |
| 2015-01-31 | $3.12B | $20.17B | 15.96% |
| 2014-10-31 | $2.91B | $19.44B | 15.02% |
| 2014-07-31 | $2.98B | $19.25B | 15.54% |
| 2014-04-30 | $3.07B | $19.44B | 16.12% |
| 2014-01-31 | $3.59B | $19.35B | 19.05% |
| 2013-10-31 | $3.81B | $18.74B | 20.67% |
| 2013-07-31 | $3.56B | $18.52B | 19.70% |
| 2013-04-30 | $3.47B | $18.67B | 19.55% |
| 2013-01-31 | $3.49B | $17.84B | 20.11% |
| 2012-10-31 | $3.44B | $17.18B | 20.00% |
| 2012-07-31 | $3.66B | $17.26B | 21.44% |
| 2012-04-30 | $3.62B | $17.11B | 21.48% |
| 2012-01-31 | $3.40B | $17.17B | 20.56% |
| 2011-10-31 | $3.39B | $16.74B | 21.07% |
| 2011-07-31 | $3.09B | $16.34B | 19.76% |
| 2011-04-30 | $3.10B | $15.97B | 20.38% |
| 2011-01-31 | $3.28B | $15.36B | 22.05% |
| 2010-10-31 | $3.18B | $14.83B | 21.80% |
| 2010-07-31 | $3.48B | $14.60B | 24.38% |
| 2010-04-30 | $3.10B | $14.63B | 22.25% |
| 2010-01-31 | $2.25B | $14.32B | 16.56% |
| 2009-10-31 | $2.11B | $13.61B | 15.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $115.249B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |